• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新发心房颤动合并慢性肾脏病的短期转归：种族重要吗？

Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?

机构信息

1 Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart & Chest Hospital Liverpool United Kingdom.

2 Aalborg Thrombosis Research Unit Department of Clinical Medicine Aalborg University Aalborg Denmark.

出版信息

J Am Heart Assoc. 2019 Feb 5;8(3):e011953. doi: 10.1161/JAHA.119.011953.

DOI:10.1161/JAHA.119.011953
PMID:30717613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6405578/
Abstract

See Article by Goto et al .

摘要

见 Goto 等人的文章。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/820d/6405578/ed28773de475/JAH3-8-e011953-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/820d/6405578/ed28773de475/JAH3-8-e011953-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/820d/6405578/ed28773de475/JAH3-8-e011953-g001.jpg

相似文献

1
Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?新发心房颤动合并慢性肾脏病的短期转归：种族重要吗？
J Am Heart Assoc. 2019 Feb 5;8(3):e011953. doi: 10.1161/JAHA.119.011953.
2
Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.心房颤动症状、治疗模式及结局的种族/民族差异：来自心房颤动更明智治疗结局登记处的见解
Am Heart J. 2016 Apr;174:29-36. doi: 10.1016/j.ahj.2015.10.028. Epub 2015 Dec 30.
3
Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.新诊断的肾功能不全房颤患者启动华法林治疗后的治疗范围内时间及结局
J Am Heart Assoc. 2017 Mar 1;6(3):e004925. doi: 10.1161/JAHA.116.004925.
4
Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.心房颤动与终末期肾病：卒中地理和种族差异原因（REGARDS）研究
Int J Cardiol. 2015 Apr 15;185:219-23. doi: 10.1016/j.ijcard.2015.03.104. Epub 2015 Mar 12.
5
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.种族/民族与心房颤动患者口服抗凝药物使用的相关性：来自更好地了解心房颤动治疗的结果登记 II 研究的结果。
JAMA Cardiol. 2018 Dec 1;3(12):1174-1182. doi: 10.1001/jamacardio.2018.3945.
6
Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.种族对65岁以上房颤患者预后（中风和死亡）的影响。
Am J Cardiol. 2015 Jul 15;116(2):230-5. doi: 10.1016/j.amjcard.2015.04.012. Epub 2015 Apr 16.
7
A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.初诊无症状与有症状房颤患者的临床特征及长期预后比较：贝尔格莱德房颤研究
Int J Cardiol. 2013 Oct 12;168(5):4744-9. doi: 10.1016/j.ijcard.2013.07.234. Epub 2013 Aug 1.
8
Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study.种族与心房颤动发病队列中的中风：来自宾夕法尼亚房颤自由研究的结果。
Heart Rhythm. 2018 Apr;15(4):487-493. doi: 10.1016/j.hrthm.2017.11.025. Epub 2018 Feb 20.
9
Serum Myeloperoxidase, Uric Acid, and the Risk of Atrial Fibrillation in Chronic Kidney Disease.血清髓过氧化物酶、尿酸与慢性肾脏病患者发生心房颤动的风险
Circ Arrhythm Electrophysiol. 2021 Apr;14(4):e009483. doi: 10.1161/CIRCEP.120.009483. Epub 2021 Apr 16.
10
Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.种族和民族差异对房颤患者的患病率、管理和结局的影响：系统评价。
Heart Rhythm. 2018 Sep;15(9):1337-1345. doi: 10.1016/j.hrthm.2018.05.019. Epub 2018 May 24.

引用本文的文献

1
Evaluation of Left Atrial Function in Patients with Paroxysmal Atrial Fibrillation Using Left Atrial Automatic Myocardial Functional Imaging Ultrasonography.应用左心房心肌自动功能成像超声心动图评估阵发性心房颤动患者的左心房功能
Cardiol Res Pract. 2023 Nov 20;2023:6924570. doi: 10.1155/2023/6924570. eCollection 2023.

本文引用的文献

1
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.新发心房颤动合并慢性肾脏病患者的管理及 1 年转归：前瞻性 GARFIELD-AF 登记研究结果。
J Am Heart Assoc. 2019 Feb 5;8(3):e010510. doi: 10.1161/JAHA.118.010510.
2
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.非维生素 K 拮抗剂口服抗凝药物在心脏病中的应用：第五部分-特殊情况。
Thromb Haemost. 2019 Jan;119(1):14-38. doi: 10.1055/s-0038-1675816. Epub 2018 Dec 31.
3
Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review.
预测非瓣膜性心房颤动患者的血栓栓塞和出血事件风险：系统评价。
Thromb Haemost. 2018 Dec;118(12):2171-2187. doi: 10.1055/s-0038-1675400. Epub 2018 Oct 30.
4
Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry.肾功能不全与心房颤动患者抗凝控制质量的关系：FANTASIIA 登记研究。
Thromb Haemost. 2018 Feb;118(2):279-287. doi: 10.1160/TH17-06-0416. Epub 2018 Jan 29.
5
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry.房颤抗栓治疗的地域差异：来自 GLORIA-AF II 期注册研究的启示。
Thromb Haemost. 2017 Dec;117(12):2376-2388. doi: 10.1160/TH17-08-0555. Epub 2017 Dec 6.
6
Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries.华法林治疗的心房颤动患者的肾功能、治疗窗时间和结局：全国注册登记的回顾性分析。
Thromb Haemost. 2017 Dec;117(12):2291-2299. doi: 10.1160/TH17-03-0198. Epub 2017 Dec 6.
7
Asian strategy for stroke prevention in atrial fibrillation.亚洲心房颤动卒中预防策略
Europace. 2015 Oct;17 Suppl 2:ii31-9. doi: 10.1093/europace/euv231.
8
New oral anticoagulants may be particularly useful for asian stroke patients.新型口服抗凝药物可能对亚洲脑卒中患者特别有用。
J Stroke. 2014 May;16(2):73-80. doi: 10.5853/jos.2014.16.2.73. Epub 2014 May 30.
9
Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study.在伴有心房颤动和肾功能衰竭的患者中平衡卒中和出血风险：瑞典心房颤动队列研究。
Eur Heart J. 2015 Feb 1;36(5):297-306. doi: 10.1093/eurheartj/ehu139. Epub 2014 Apr 9.
10
Estimating glomerular filtration rate in Asian subjects: where do we stand?评估亚洲人群的肾小球滤过率：我们目前处于什么状况？
Kidney Int. 2011 Sep;80(5):439-40. doi: 10.1038/ki.2011.197.